LEONARD-MERON BIOSCIENCES
Leonard Meron Biosciences, Inc. (LMB) is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti-infective drugs. The Company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, or CRBSIs. Recently, the U.S. Food and Drug Administration (FDA) granted a Qualified Infectious Disease Product (QIDP) designation for the antibiotic lock solution, Mino-Lok.
LEONARD-MERON BIOSCIENCES
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2013-01-01
Address:
Cranford, New Jersey, United States
Country:
United States
Status:
Active
Similar Organizations
Neurosurgeon Todd Kuether, MD
Todd Kuether is a Neurosurgeon in the healthcare industry focused on the brain and spine.
Sidero Bioscience
Sidero Bioscience operates in the healthcare industry focusing on biotechnology business.
Vetica Labs
Vetica Labs is operates in the healthcare industry focusing on biotechnology business.
Founder
More informations about "Leonard-Meron Biosciences"
Leonard-Meron Biosciences - Crunchbase Company Profile
Leonard Meron Biosciences, Inc. (LMB) is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a …See details»
Citius Pharmaceuticals Completes Acquisition of Leonard-Meron …
MAYNARD, Mass., April 4, 2016 /PRNewswire/ -- Citius Pharmaceuticals, Inc. (OTCQB: CTXR) ("Citius") today announced completion of the acquisition of Leonard-Meron Biosciences, Inc. …See details»
About - Board of Directors - Person Details - Citius Pharma
Leonard Mazur, Co-Founder, CEO and Chairman of the Board of Directors Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable success in …See details»
Organization | Leonard-Meron Biosciences, Inc. - Purdue University
Leonard-Meron Biosciences, Inc. Report issue For profit Phase 3 Founded: Cranford NJ United States (2013)See details»
Veteran Citius CEO Uses 'All-In' Approach to Bring New …
Nov 27, 2023 · Leonard Mazur is a 50-year veteran in the pharmaceutical field with a myriad of product launches, patents, and titles under his belt. But it wasn't until he turned 50 that he …See details»
Citius Pharmaceuticals Completes Acquisition of Leonard-Meron …
Apr 5, 2016 · Citius Pharmaceuticals, Inc. today announced completion of the acquisition of Leonard-Meron Biosciences, Inc. Pursuant to the acquisition, Citius acquired all of the …See details»
Citius Pharmaceuticals Announces Key Management Realignment …
Apr 13, 2022 · Leonard Mazur named Chairman of the Board of Directors and CEO of Citius. Citius co-founder, Myron Holubiak to transition from President & CEO to Executive Vice …See details»
About - Board of Directors - Person Details - Citius Pharma
Leonard Mazur, Co-Founder, CEO & Chairman of the Board of Director Mr. Mazur is an accomplished entrepreneur and pharmaceutical industry executive with notable …See details»
Citius Pharma Completes Acquisition Of Leonard-Meron Biosciences
Apr 4, 2016 · LMB is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration on anti …See details»
Leonard-Meron Biosciences Inc - Company Profile and News
Leonard-Meron Biosciences, Inc. operates as a late-stage specialty pharmaceutical company. The Company focuses on the development and commercialization of critical care products …See details»
Leonard-Meron Biosciences acquired by Citius Pharmaceuticals
Apr 4, 2016 · Leonard-Meron Biosciences Leonard-Meron Biosciences is a healthcare industry focusing on biotechnology business. Acquiring Organization: Citius Pharmaceuticals Citius …See details»
Citius Pharmaceuticals, Inc. - About - Board of Directors - Person …
Holubiak was co-founder, director and CEO of Leonard-Meron Biosciences, Inc. prior to its merger with Citius in March 2016 and served as the Company's President and CEO. From 1998 to …See details»
Citius Pharmaceuticals, Inc. Announces Management Changes
Apr 4, 2016 · Citius Pharmaceuticals, Inc. announced completion of the acquisition of Leonard-Meron Biosciences, Inc. Prior to the acquisition, Mr. Leonard Mazur was the Chief Executive …See details»
Leonard-Meron Biosciences - PitchBook
Information on acquisition, funding, investors, and executives for Leonard-Meron Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Leonard Mazur - Chief Executive Officer - Citius
Chief Executive Officer at Citius Pharmaceuticals, Inc. (formerly Leonard Meron Biosciences, Inc.) · Featured in numerous editions of Who's Who in America, Who's Who in Medicine and...See details»
Bringing Novel Solutions to Market for Unmet Needs
The story of Citius Pharmaceuticals in its current incarnation began in 2013 when Myron Holubiak and Leonard Mazur founded Leonard-Meron Biosciences (LMB RX) to in-license one such …See details»
Citius Pharmaceuticals Signs Letter of Intent to Acquire Leonard …
Mar 7, 2016 · Leonard Meron Biosciences, Inc. (LMB) is a private, late-stage specialty pharmaceutical company focused on the development and commercialization of critical care …See details»
Antibiotic lock and Mino-Lok in Catheter-related Infections - ICH …
Aug 31, 2016 · April 18, 2022 updated by: Leonard-Meron Biosciences, Inc. Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of …See details»
FDA Grants QIDP Designation to LMB for Mino-Lok™, a Novel …
CRANFORD, N.J., Oct. 12, 2015 /PRNewswire/ -- Leonard Meron Biosciences, Inc. (LMB) today announced that the U.S. Food and Drug Administration (FDA) has granted a Qualified …See details»
Disodium edetate/ethyl alcohol/minocycline - Citius Pharmaceuticals
14 May 2024 Leonard-Meron Biosciences completes phase-III trial in Catheter infections (In children, In the elderly, In adults, Adjunctive therapy) in USA, India and Puerto Rico …See details»